UK signs deal with Pfizer/BioNTech for further 35 million vaccine doses

24 August 2021
biontech_vaccine_large

PFE)/BioNTech (Nasdaq: BNTX) COVID-19 vaccine, to be delivered from the second half of next year. This adds to the 100 million doses of the vaccine, now trade named Comirnaty, that the British government has already contracted to buy.

The value of the contract was not disclosed, but early this month Pfizer raised the price of the vaccine to19.50 euros ($23.13) per dose versus 15.50 euros previously

The government, through the Vaccine Taskforce, is putting in place preparations to future-proof the country from the threat of COVID-19 and its variants through safe and effective vaccines, as the UK’s world-renowned vaccination program continues to protect the population.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Biotechnology